£29.2m Placing, Subscription and Open Offer – Shield Therapeutics

Peel Hunt is acting as NOMAD, joint Corporate Broker and joint Bookrunner to Shield Therapeutics plc on the issue of New Ordinary Shares pursuant to a Placing (£19.9m), a Subscription (c.£5.1m) and an Open Offer (£4.2m) at a price of 30 pence per New Ordinary Share to raise gross proceeds of up to c. £29.2 million, as announced on 26th February, 2021.